Clinical trial
Characterization of Metabolic Changes in the Glioma Tumor Tissue Induced by Transient Fasting (ERGO3)
NCT04461938 is registered in ClinicalTrials.gov with Goethe University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Metabolic Changes in the Glioma Tumor Tissue Induced by Transient Fasting (ERGO3)
- Lead sponsor
- Goethe University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 19, 2020
- Completion date
- June 30, 2025
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glioma, mixed